Interferon β treatment for multiple sclerosis

被引:9
|
作者
Goodin, DS [1 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
来源
LANCET | 1999年 / 353卷 / 9151期
关键词
D O I
10.1016/S0140-6736(05)75165-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:495 / 496
页数:2
相关论文
共 50 条
  • [21] Neutralising antibodies to interferon β during the treatment of multiple sclerosis
    Polman, CH
    Kappos, L
    Petkau, J
    Thompson, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (08): : 1162 - 1162
  • [22] Assessment of cancer risk with β-interferon treatment for multiple sclerosis
    Kingwell, Elaine
    Evans, Charity
    Zhu, Feng
    Oger, Joel
    Hashimoto, Stanley
    Tremlett, Helen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10): : 1096 - 1102
  • [23] Psoriasis during interferon beta treatment for multiple sclerosis
    La Mantia, Loredana
    Capsoni, F.
    NEUROLOGICAL SCIENCES, 2010, 31 (03) : 337 - 339
  • [24] Treatment of multiple sclerosis with interferon β1b
    Dhib-Jalbut, S
    McFarland, HF
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 467 - 480
  • [25] Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β
    Hegen, Harald
    Auer, Michael
    Deisenhammer, Florian
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (12) : 1803 - 1819
  • [26] Adherence to interferon β treatment in Kosovan multiple sclerosis registry
    Myftiu, Blerim
    Komoni, Edmond
    Malazogu, Edita
    Jashari, Fisnik
    Rashiti, Shpresa Beqiri
    Pushka, Melihate
    Biqku, Adnan
    Prebreza, Syzana Alickaj
    Spanca, Valbona Rrahmani
    Bytyqi, Jehona Rrustemi
    Shala, Nexhmedin
    Blyta, Afrim
    ITALIAN JOURNAL OF MEDICINE, 2024, 18 (01)
  • [27] Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis
    Ghasami, Keyvan
    Faraji, Fardin
    Fazeli, Masoud
    Ghazavi, Ali
    Mosayebi, Ghasem
    IRANIAN JOURNAL OF IMMUNOLOGY, 2016, 13 (01) : 16 - 26
  • [28] Lipoatrophy in multiple sclerosis patients during interferon treatment
    Tilbery, C.
    Fernandes, I.
    Mendes, M. F.
    Thomaz, R.
    MULTIPLE SCLEROSIS, 2006, 12 : S84 - S85
  • [29] Interferon beta in the treatment of multiple sclerosis - Mechanisms of action
    Yong, VW
    Chabot, S
    Stuve, O
    Williams, G
    NEUROLOGY, 1998, 51 (03) : 682 - 689
  • [30] Migraines linked to interferon-β treatment of multiple sclerosis
    Khromov, A
    Segal, M
    Nissinoff, J
    Fast, A
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2005, 84 (08) : 644 - 647